Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-8,398
Closed -$605K 72
2024
Q4
$605K Sell
8,398
-1,099
-12% -$85.9K 0.04% 65
2024
Q3
$774K Buy
+9,497
New +$760K 0.05% 61
2017
Q3
Sell
-23,852
Closed -$1.08M 82
2017
Q2
$1.08M Buy
23,852
+1,565
+7% +$69.1K 0.2% 68
2017
Q1
$948K Sell
22,287
-408
-2% -$16.6K 0.18% 76
2016
Q4
$911K Buy
+22,695
New +$876K 0.14% 96

Other funds holding HOLX

Ninety One North America's HOLX Position: Q1 2025 in Review

Ninety One North America sold out of Hologic (HOLX) in Q1 2025, closing a stake of 8,398 shares — an estimated $605K sold.

Ninety One North America first reported a position in HOLX in Q4 2016 and held it in 5 quarters. The position peaked at $1.08M in Q2 2017. 706 funds tracked by Wall St. Rank hold HOLX as of Q1 2025.

  • Ninety One North America reported no remaining Hologic position as of Q1 2025 after selling out during the quarter.
  • Ninety One North America sold 8,398 Hologic shares in Q1 2025, an estimated $605K.
  • Ninety One North America first reported a position in Hologic in Q4 2016 and held it in 5 quarters.
  • Ninety One North America's Hologic position peaked at $1.08M in Q2 2017.
  • 706 funds tracked by Wall St. Rank held Hologic as of Q1 2025.

Based on Ninety One North America's 13F filing for Q1 2025, filed 30 Apr 2025.